Express FP 10 Vaccine Gains New Label Claim

August 31, 2011 06:49 AM
 
Express FP 10 Vaccine  Gains New Label Claim

Boehringer Ingelheim Vetmedica, Inc., has enhanced Express FP 10, its modified-live virus/bacterin vaccine combination, which now offers protection against Leptospira hardjo-bovis (Leptospira borgpetersenii serovar hardjo, type hardjo-bovis).

The L. hardjo-bovis substrain is associated with early embryonic deaths, poor conception rates and weak calves, as well as other reproductive losses in cattle. Express FP 10 offers five-way viral protection and protection against L. hardjo-bovis in just one syringe. L. hardjo-bovis is the only hardjo that is isolated in the U.S.; all cattle herds are at risk for infection from it.

For more information, visit www.bi-vetmedica.com.

Back to news


Million Dollar Wildfire Relief Challenge

Click here to learn more about the Million Dollar Wildfire Relief Challenge, and see how you can help in the rebuilding effort.


 

Comments

 
Spell Check

No comments have been posted to this News Article

Corn College TV Education Series

2014_Team_Shot_with_Logo

Get nearly 8 hours of educational video with Farm Journal's top agronomists. Produced in the field and neatly organized by topic, from spring prep to post-harvest. Order now!

Markets

Market Data provided by Barchart.com
brought-by
Close